
|Articles|March 1, 2001
The American Journal of Managed Care
- March 2001
- Volume 7
- Issue 3
Renal Effects of Angiotensin-Converting Enzyme Inhibitors That Result in Cost Savings and Improved Patient Outcomes
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
4
Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology
5